This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Implantable Collamer Lens industry.
How has the implantable collamer lens market size changed in recent years, and what is the outlook ahead?
The implantable collamer lens market size has grown strongly in recent years. It will grow from $19.53 billion in 2024 to $20.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.10%. The growth in the historic period can be attributed to increased awareness of vision correction options, growth in adoption of minimally invasive surgeries, rise in prevalence of refractive errors, favorable reimbursement policies in key regions, and increased investment in ophthalmic research.
The implantable collamer lens market size is expected to see strong growth in the next few years. It will grow to $27.25 billion in 2029 at a compound annual growth rate (CAGR) of 6.84%. The growth in the forecast period can be attributed to rising demand for permanent vision correction solutions, increasing prevalence of myopia and astigmatism, growing focus on customized and patient-specific implants, an aging population with rising eye care needs, and expansion of outpatient surgical centers. Major trends in the forecast period include the integration of AI in preoperative planning, the development of foldable and biocompatible lens materials, collaboration between manufacturers and healthcare providers, technological innovations in lens materials and designs, and advances in implantable lens technology.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp
What are the top economic and technological drivers pushing implantable collamer lens market growth?
The rising prevalence of vision disorders is expected to drive the implantable collamer lens market going forward. Vision disorders refer to conditions that affect the ability to see clearly, characterized by a gradual decline in visual acuity and eye health. Vision disorders are increasing globally due to factors such as an aging population, increased screen time, and rising prevalence of conditions like myopia and age-related macular degeneration. Implantable Collamer Lenses (ICLs) provide an effective solution for correcting vision disorders such as myopia, hyperopia, and astigmatism by offering a safe, reversible alternative to traditional refractive surgeries like LASIK. For instance, in August 2023, according to a report published by the World Health Organization, a Switzerland-based specialized agency of the United Nations, globally, over 2.2 billion people suffer from near or distance vision impairment, with 1 billion of these cases being preventable or still unaddressed. Moreover, in July 2023, according to the Welsh Government, a UK-based government agency, an estimated 1,563 new certificates of vision impairment (CVI) were issued in 2021-22, reflecting a 49.1% rise from the previous year. Therefore, the increasing prevalence of vision disorders is driving the growth of the implantable collamer lens market.
Impact Of The Aging Population On The Growth Of The Implantable Collamer Lens Market
The aging population is significantly driving the growth of the implantable collamer lens market in the future. The aging population is rising globally due to increased life expectancy, advancements in healthcare, and declining birth rates, leading to a growing proportion of elderly individuals in many societies. Implantable collamer lenses (ICLs) are beneficial for the aging population by providing a permanent solution for age-related vision issues, such as presbyopia, allowing clearer, natural vision without the need for reading glasses or contact lenses. For instance, in July 2024, according to the House of Commons Library, the UK-based library and information resource of the lower house of the British Parliament, in 2022, individuals aged 65 and over accounted for approximately 19% of the UK’s population, totaling around 12.7 million people. By 2072, this demographic is projected to increase to 22.1 million, representing 27% of the population. Therefore, an aging population is driving the growth of the implantable collamer lens market.
How is the implantable collamer lens market segmented by product, application, and end-user?
The implantable collamer lens market covered in this report is segmented –
1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)
2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques
3) By Application: Myopia, Hyperopia, Astigmatism
4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User
Subsegments:
1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia
2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report
What are the key trends shaping the implantable collamer lens market in the forecast period?
Major companies operating in the implantable collamer lens (ICL) market are focusing on advancements in lens technology and gaining approval to gain a competitive edge in the industry. The Implantable Collamer Lens is designed to correct refractive vision errors, offering a minimally invasive solution for myopia and astigmatism. For instance, in April 2022, STAAR Surgical Company, a US-based manufacturer and marketer of implantable lenses and companion delivery systems for the eye, revealed that the U.S. Food and Drug Administration (FDA) has approved the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for correcting myopia and myopia with astigmatism. The EVO Visian ICL lens is designed to correct or reduce nearsightedness ranging from -3.0 D to -20.0 D and address astigmatism between 1.0 D and 4.0 D.
Which leading companies are dominating the implantable collamer lens market landscape?
Major companies operating in the implantable collamer lens market are STAAR Surgical Company
Which geographic areas are expected to offer the highest growth opportunities in theimplantable collamer lens market?
North America was the largest region in the implantable collamer lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Implantable Collamer Lens Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20840
Need Customized Data On Implantable Collamer Lens Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
